Specifications
- Purity
- ≥98% (HPLC)
- Appearance
- White to off-white powder
- Identity
- 1H-NMR
Properties
- Solvents
- water (30 mg/ml)
Category: Metabolites
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
NADP+ is the oxidized form of the electron donor nicotinamide adenine dinucleotide phosphate. It is a cofactor used in anabolic reactions, such as the Calvin cycle, lipid syntheses and nucleic acid syntheses, which require NADPH as a reducing agent. It serves as a cofactor in various biological reactions. In addition, the balance between these reduced and oxidized forms plays key roles in diverse cellular functions, including cell survival, the maintenance of redox status and intracellular signaling. For example, binding of NADP+ to β-subunits of Kv channels activates ion transport, whereas NADPH stabilizes channel inactivation. NADP+ is biosynthesized from NAD+ by NAD kinase, with ATP as the phosphoryl donor. NADP+ might be useful for immunometabolism research.
Synonyms | Coenzyme II, β-NADP, NADP+, TPN, Triphosphopyridine nucleotide sodium salt hydrate |
---|---|
Purity | ≥98% (HPLC) |
Appearance | White to off-white powder |
CAS-Number | 698999-85-8 |
Molecular Formula | C21H27N7NaO17P3 . xH2O |
Molecular Weight | 765.39 (anhydrous) |
Identity | 1H-NMR |
Solvents | water (30 mg/ml) |
Smiles | O[C@H]1[C@@H](OP(O)(O)=O)[C@H](N2C=NC3=C2N=CN=C3N)O[C@@H]1COP([O-])(OP(OC[C@@H]4[C@@H](O)[C@@H](O)[C@H]([N+]5=CC(C(N)=O)=CC=C5)O4)([O-])=O)=O.[Na+] |
InChi Key | JNUMDLCHLVUHFS-QYZPTAICSA-M |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light and moisture. |
Use / Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Hazard statements | H319 |
Precautionary statements | P280-P305 + P351 + P338-P337 + P313 |
GHS Symbol | GHS07 |
Signal word | Warning |
Transportation | Not dangerous goods |
References | (1) F. Shi, et al., Acta Biochim. Biophys. Sin. 41, 352 (2009), (2) J.B. Jackson, BBA 1817, 1839 (2012), (3) M. Nakamura, et al., Circ. Res. 111, 604 (2012), (4) P.J. Kilfoil, et al., Circ. Res. 112, 721 (2013), (5) M. Ziegler, FEBS J. 272, 4561 (2014), (6) R. Ramalho, et al., Sem. Immunopathol. 42, 279 (2020) |
InChi | InChI=1S/C21H28N7O17P3.Na/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32,/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39),/q,+1/p-1/t10-,11-,13-,14-,15-,16-,20-,21-,/m1./s1 |
Quantity | 500 mg, 1 g, Bulk |